What is Daniel Kaplon, MD?
Led by Dr. Daniel Kaplon, a board-certified urologist with over a decade of clinical experience, the practice serves as a cornerstone for advanced urological care in Florida. The organization distinguishes itself through a deep specialization in minimally invasive robotic surgery, specifically leveraging the da Vinci surgical system to treat complex conditions such as prostate cancer. Beyond oncology, the practice provides comprehensive care for kidney stones, male infertility, and hormonal imbalances, maintaining a reputation for personalized, high-quality patient outcomes. By integrating cutting-edge surgical technology with patient-centric care, the practice has established a robust market position as a leader in robotic-assisted urological procedures.
How much funding has Daniel Kaplon, MD raised?
Daniel Kaplon, MD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Daniel Kaplon, MD
PPP
Public-Private Partnership
What's next for Daniel Kaplon, MD?
The infusion of capital marks a pivotal transition for the practice as it moves into a phase of operational scaling and technological refinement. With the recent financing, the organization is expected to prioritize the acquisition of next-generation surgical equipment and the expansion of its clinical support staff to accommodate increasing patient volume. Furthermore, the strategic allocation of these funds will likely facilitate the integration of advanced diagnostic tools, ensuring that the practice remains at the forefront of urological innovation. As the healthcare sector continues to shift toward value-based care and minimally invasive solutions, Dr. Kaplon’s practice is strategically aligned to capture further market share while maintaining its commitment to clinical excellence and patient safety.
See full Daniel Kaplon, MD company page
